e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Asthma and allergy: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of CD4-endotypes in severe allergic asthma for future precision medicine
G. Ulrich-Merzenich (Bonn, Germany)
Source:
International Congress 2017 – Asthma and allergy: from the bench to the bedside
Session:
Asthma and allergy: from the bench to the bedside
Session type:
Poster Discussion
Number:
3553
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Ulrich-Merzenich (Bonn, Germany). Characterization of CD4-endotypes in severe allergic asthma for future precision medicine. 3553
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Characterisation of a chronic pre-clinical model of allergic asthma
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015
A novel evaluation of the impact of severe allergic asthma in children: The family perspective
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Anti-IgE treatment: An alternative for severe allergic occupational asthma
Source: Annual Congress 2012 - Asthma and COPD at work: what are the effects of exposure and risk factors?
Year: 2012
Comparative analysis of allergic and non-allergic severe persistent asthma
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008
Efficacy of Omalizumab in adult and pediatric severe allergic asthma according to presence of multiple allergic comorbidities: evidence from the STELLAIR study.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Translational strategy for allergic asthma
Source: International Congress 2014 – Sadoul Lecture “From molecules and cells to phenotypes: deciphering chronic airways disease” followed by related presentations
Year: 2014
Continuing allergic inflammation determines asthma chronicity in children
Source: Eur Respir J 2006; 28: Suppl. 50, 850s
Year: 2006
Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma
Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy
Year: 2011
Assessing severe asthma
Source: Eur Respir J 2016; 48: 611-613
Year: 2016
The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019
Practical use of control of allergic rhinitis and asthma test in a telehealth service
Source: International Congress 2018 – Primary care management of respiratory conditions
Year: 2018
Allergic rhinitis and coexistence of allergic rhinitis and asthma at Greek children. Comparison of clinical and laboratory pararameters
Source: Eur Respir J 2006; 28: Suppl. 50, 255s
Year: 2006
Evaluation in a severe asthma expert center improves asthma outcomes.
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept